Sonoma Biotherapeutics

Tr1X

This biotechnology company develops allogeneic engineered regulatory T cell therapies to treat patients with autoimmune and inflammatory diseases.

Quell Therapeutics

This clinical-stage company develops engineered T-regulatory cell therapies for patients with autoimmune diseases, inflammatory conditions and organ transplant rejection.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Regcell

This biotechnology company develops regulatory T-cell therapies using an epigenetic reprogramming platform to treat patients with autoimmune diseases and inflammatory conditions.

Luminary Therapeutics

This biotechnology company develops cell therapies to treat patients with cancers and autoimmune diseases.

Egle Therapeutics

This biotechnology company develops precision medicines that modulate regulatory T cells to treat patients with autoimmune diseases and cancer.

Abata Therapeutics

This company develops regulatory T cell therapies to treat patients with severe autoimmune and inflammatory diseases including progressive multiple sclerosis and type 1 diabetes.

TRexBio

This biotechnology company develops immunoregulatory medicines for patients with autoimmune and inflammatory diseases by decoding regulatory T cell function in human tissues.